1 |
docetaxel
(980 times)
|
Pharmacology (237 times)
|
NPs (70 times) PTX (58 times) NSCLC (37 times)
|
1999 The pharmacokinetics of epirubicin and docetaxel in combination in rats.
|
2 |
dendrotoxin
(47 times)
|
Neurology (19 times)
|
4-AP (7 times) TEA (5 times) MNTB (4 times)
|
1985 Electrophysiological and neurobiochemical evidence for the blockade of a potassium channel by dendrotoxin.
|
3 |
alpha-dendrotoxin
(13 times)
|
Neurology (3 times)
|
4-AP (4 times) TEA (4 times) MCDP (3 times)
|
1991 Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
|
4 |
dinophysistoxin
(11 times)
|
Toxicology (4 times)
|
OA (11 times) DSP (6 times) DSTs (2 times)
|
2004 Rapid determination of polyether marine toxins using liquid chromatography-multiple tandem mass spectrometry.
|
5 |
Deltex
(7 times)
|
Neoplasms (3 times)
|
BBAP (3 times) ARTD9 (2 times) DTX3L (2 times)
|
2006 Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains.
|
6 |
detoxification
(6 times)
|
Substance-Related Disorders (4 times)
|
ATOS (4 times) MT (3 times) RR (3 times)
|
2003 Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
|
7 |
detoxification efflux carriers
(4 times)
|
Science (1 time)
|
MATE (3 times) ABA (1 time) GO (1 time)
|
2017 Two tonoplast MATE proteins function as turgor-regulating chloride channels in Arabidopsis.
|
8 |
docetaxel trihydrate
(4 times)
|
Antineoplastic Agents (2 times)
|
CCM (1 time) DTX-HA (1 time) NMs (1 time)
|
2012 [Comparative examination of preparation time in docetaxel hydrate formulation].
|
9 |
demonstrated that docetaxel
(2 times)
|
Neoplasms (2 times)
|
CRPC (1 time) MRP4 (1 time)
|
2003 A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer.
|
10 |
dendrotoxin-sensitive
(2 times)
|
Brain (1 time)
|
DS (1 time) MAP2 (1 time)
|
2000 Firing properties and dendrotoxin-sensitive sustained potassium current in vestibular nuclei neurons of the hatchling chick.
|
11 |
polymer-docetaxel
(2 times)
|
Biomedical Engineering (1 time)
|
HPMA (1 time)
|
2015 Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism.
|
12 |
1,4-beta-D-glucan-PPO-docetaxel
(1 time)
|
Biochemistry (1 time)
|
CMC (1 time) DP (1 time) MWD (1 time)
|
2018 Amphiphilic polymeric micelles originating from 1,4-beta-D-glucan-g-polyphenylene oxide as the carriers for delivery of docetaxel and the corresponding release behaviors.
|
13 |
2,4-diethyl-9H-thioxanthen-9-one
(1 time)
|
Chemistry Techniques, Analytical (1 time)
|
ITX (2 times) ASE (1 time) CV (1 time)
|
2006 Determination of isopropylthioxanthone (ITX) in milk, yoghurt and fat by HPTLC-FLD, HPTLC-ESI/MS and HPTLC-DART/MS.
|
14 |
Decision Tree Explainer
(1 time)
|
Biology (1 time)
|
COVID-19 (1 time) ML (1 time) RF (1 time)
|
2021 Explaining machine learning based diagnosis of COVID-19 from routine blood tests with decision trees and criteria graphs.
|
15 |
deliver the chemotherapy drug docetaxel
(1 time)
|
Biocompatible Materials (1 time)
|
chemo-SDT (1 time) PCNPs (1 time) ROS (1 time)
|
2022 Concise Nanoplatform of Phycocyanin Nanoparticle Loaded with Docetaxel for Synergetic Chemo-sonodynamic Antitumor Therapy.
|
16 |
delivering the lipophilic chemotherapeutic docetaxel
(1 time)
|
Nanotechnology (1 time)
|
dcNPs (1 time) HA (1 time)
|
2015 Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.
|
17 |
delta-dendrotoxin
(1 time)
|
Toxicology (1 time)
|
KTX (1 time)
|
2000 On the kaliotoxin and dendrotoxin binding sites on rat brain synaptosomes.
|
18 |
delta-TT and docetaxel
(1 time)
|
Chemistry (1 time)
|
delta-TT (1 time) PCa (1 time)
|
2023 Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells.
|
19 |
demonstrated that curcumin, like docetaxel
(1 time)
|
Natural Science Disciplines (1 time)
|
MDSCs (1 time) sCLU (1 time)
|
2016 Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
|
20 |
desire to develop docetaxel
(1 time)
|
Drug Therapy (1 time)
|
DPLs (1 time)
|
2016 Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation.
|
21 |
determine the behavior of docetaxel
(1 time)
|
Antineoplastic Agents (1 time)
|
PTX (1 time)
|
2003 Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
|
22 |
Dettox ABC
(1 time)
|
Microbiology (1 time)
|
---
|
1982 A laboratory evaluation of a new disinfectant cleaner for fibreoptic instruments.
|
23 |
developed to co-load docetaxel
(1 time)
|
Biomedical Engineering (1 time)
|
His (1 time) HSA (1 time) RGD (1 time)
|
2022 Multifunctional Human Serum Albumin Fusion Protein as a Docetaxel Nanocarrier for Chemo-photothermal Synergetic Therapy of Ovarian Cancer.
|
24 |
developed to specifically target docetaxel
(1 time)
|
Pharmacological Phenomena (1 time)
|
DLS (1 time) fWGA (1 time) MD (1 time)
|
2020 Docetaxel-Loaded Disulfide Cross-Linked Nanoparticles Derived from Thiolated Sodium Alginate for Colon Cancer Drug Delivery.
|
25 |
dexamethasone
(1 time)
|
Dentistry (1 time)
|
pQCT (1 time)
|
2015 Effect of dexamethasone on mandibular bone biomechanics in rats during the growth phase as assessed by bending test and peripheral quantitative computerized tomography.
|
26 |
dextrorphan
(1 time)
|
Drug Therapy (1 time)
|
3-HM (1 time) 3-MM (1 time) DEX (1 time)
|
2000 Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening.
|
27 |
diabetic+troxerutin
(1 time)
|
Endocrinology (1 time)
|
DI (1 time) TX (1 time)
|
2020 Can troxerutin pretreatment prevent testicular complications in prepubertal diabetic male rats?
|
28 |
Dictyoglomus thermophilum xylanase B
(1 time)
|
Polymers (1 time)
|
TMX (1 time)
|
2005 Heat-resistant oxygen-carrying hemoproteins consist of recombinant xylanases and synthetic iron(II) porphyrin.
|
29 |
did the snake toxin dendrotoxin
(1 time)
|
Biology (1 time)
|
ChTX (1 time) KTX (1 time)
|
1998 The myth of scorpion suicide: are scorpions insensitive to their own venom?
|
30 |
directly targeting docetaxel
(1 time)
|
Nanotechnology (1 time)
|
DLS (1 time) fWGA (1 time) PDI (1 time)
|
2021 Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy.
|
31 |
docetaxel alone
(1 time)
|
Health Services (1 time)
|
ACD (1 time) ACP (1 time) CIPN (1 time)
|
2012 Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
|
32 |
docetaxel injection
(1 time)
|
Natural Science Disciplines (1 time)
|
DPM (1 time)
|
2016 A simple method to improve the stability of docetaxel micelles.
|
33 |
Docetaxel-based chemotherapy
(1 time)
|
Medicine (1 time)
|
ADT (1 time) CI (1 time) HR (1 time)
|
2016 Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.
|
34 |
dose-limiting toxicity occurred in only one patient at level II
(1 time)
|
Neoplasms (1 time)
|
MTD (1 time) RD (1 time)
|
2010 Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
|
35 |
double-targeted docetaxel
(1 time)
|
Pharmacology (1 time)
|
---
|
2013 Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.
|
36 |
DTX-HA-sPLGA XNPs
(1 time)
|
Biomedical Engineering (1 time)
|
---
|
2021 Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
|
37 |
DTX-NPs
(1 time)
|
Nanotechnology (1 time)
|
NPs (1 time)
|
2018 Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex nanoparticles for docetaxel delivery in ovarian cancer.
|
38 |
DTX@VTX NP
(1 time)
|
Biocompatible Materials (1 time)
|
MDSCs (1 time) TME (1 time)
|
2021 DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
|
39 |
dual aptamers-targeted docetaxel
(1 time)
|
Biomedical Engineering (1 time)
|
USI (1 time)
|
2017 A Smart Responsive Dual Aptamers-Targeted Bubble-Generating Nanosystem for Cancer Triplex Therapy and Ultrasound Imaging.
|
40 |
Dynophysis toxins
(1 time)
|
Chemistry Techniques, Analytical (1 time)
|
AZAs (1 time) MRM (1 time) OA (1 time)
|
2014 Intralaboratory validation of a fast and sensitive UHPLC/MS/MS method with fast polarity switching for the analysis of lipophilic shellfish toxins.
|
41 |
heparin-docetaxel
(1 time)
|
Pharmacology (1 time)
|
TCA (1 time)
|
2013 Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy.
|
42 |
P123-docetaxel
(1 time)
|
|
---
|
2015 Preparation of pH Sensitive Pluronic-Docetaxel Conjugate Micelles to Balance the Stability and Controlled Release Issues.
|
43 |
PNP-DTX than docetaxel
(1 time)
|
Neoplasms (1 time)
|
MTD (1 time) PNP-DTX (1 time) PR (1 time)
|
2016 Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model.
|
44 |
polyphosphazene-docetaxel
(1 time)
|
Nanotechnology (1 time)
|
AA (1 time) mPEG (1 time)
|
2017 Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
|